Expert: Inadequate FDA Foreign Inspections Contribute To Shortages, Poor Generics
As FDA asks for more authority to address prescription drug shortages, a leading expert on supply chains is arguing the agency’s inability to keep up with regular inspections of overseas facilities that produce generic drugs is a major contributor to shortages, with FDA failing to identify quality issues until they become disruptive.